🇺🇸 FDA
Patent

US 11364261

Alleviating common cold and influenza symptoms with molecular hydrogen

granted A61KA61K33/06A61K47/02

Quick answer

US patent 11364261 (Alleviating common cold and influenza symptoms with molecular hydrogen) held by H2 Universe LLC expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
H2 Universe LLC
Grant date
Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K33/06, A61K47/02, A61K47/10, A61K47/26